1. Liang XJ, Chen C, Zhao Y, Wang PC. Circumventing tumor resistance to chemotherapy by nanotechnology. Methods Mol Biol 2010;596:467-88. [ DOI:10.1007/978-1-60761-416-6_21] 2. Martinez-Espinosa R, Arguello-Garcia R, Saavedra E, Ortega-Pierres G. Albendazole induces oxidative stress and DNA damage in the parasitic protozoan Giardia duodenalis. Front Microbiol 2015;6:800. [ DOI:10.3389/fmicb.2015.00800] 3. Arguello-Garcia R, Cruz-Soto M, Gonzalez-Trejo R, Paz-Maldonado LM, Bazan-Tejeda ML, Mendoza-Hernandez G, et al. An antioxidant response is involved in resistance of Giardia duodenalis to albendazole. Front Microbiol 2015;6:286. [ DOI:10.3389/fmicb.2015.00286] 4. Chu SW, Badar S, Morris DL, Pourgholami MH. Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole. Anticancer Res 2009;29:3791-6. 5. Holden-Dye L, Walker RJ. Anthelmintic drugs and nematicides: studies in Caenorhabditis elegans. WormBook 2014:1-29. [ DOI:10.1895/wormbook.1.143.2] 6. Pourgholami MH, Woon L, Almajd R, Akhter J, Bowery P, Morris DL. In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. Cancer Lett 2001;165:43-9. [ DOI:10.1016/S0304-3835(01)00382-2] 7. Baltruskeviciene E, Schveigert D, Stankevicius V, Mickys U, Zvirblis T, Bublevic J, et al. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding. BMC Cancer 2017;17:607. [ DOI:10.1186/s12885-017-3575-z] 8. Matsuda T, Okuyama A. The estimates of 5-year colorectal cancer prevalence in adult population in 2012. Jpn J Clin Oncol 2017;47:669-70. [ DOI:10.1093/jjco/hyx089] 9. Cho YC, Nguyen TT, Park SY, Kim K, Kim HS, Jeong HG, et al. Bromopropane Compounds Increase the Stemness of Colorectal Cancer Cells. Int J Mol Sci 2017;18.pii: E1888. [ DOI:10.3390/ijms18091888] 10. Castro LS, Kviecinski MR, Ourique F, Parisotto EB, Grinevicius VM, Correia JF, et al. Albendazole as a promising molecule for tumor control. Redox Biol 2016;10:90-9. [ DOI:10.1016/j.redox.2016.09.013] 11. Oxberry ME, Reynoldson JA, Thompson RC. The binding and distribution of albendazole and its principal metabolites in Giardia duodenalis. J Vet Pharmacol Ther 2000;23:113-20. [ DOI:10.1046/j.1365-2885.2000.00254.x] 12. Oxberry ME, Thompson RC, Reynoldson JA. Evaluation of the effects of albendazole and metronidazole on the ultrastructure of Giardia duodenalis, Trichomonas vaginalis and Spironucleus muris using transmission electron microscopy. Int J Parasitol 1994;24:695-703. [ DOI:10.1016/0020-7519(94)90123-6] 13. Tang Y, Liang J, Wu A, Chen Y, Zhao P, Lin T, et al. Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis. ACS Appl Mater Interfaces 2017;9:26648-64. [ DOI:10.1021/acsami.7b05292] 14. Krucken J, Fraundorfer K, Mugisha JC, Ramunke S, Sifft KC, Geus D, et al. Reduced efficacy of albendazole against Ascaris lumbricoides in Rwandan schoolchildren. Int J Parasitol Drugs Drug Resist 2017;7:262-71. [ DOI:10.1016/j.ijpddr.2017.06.001] 15. Zhang X, Zhao J, Gao X, Pei D, Gao C. Anthelmintic drug albendazole arrests human gastric cancer cells at the mitotic phase and induces apoptosis. Exp Ther Med 2017;13:595-603. [ DOI:10.3892/etm.2016.3992] 16. Patel K, Doudican NA, Schiff PB, Orlow SJ. Albendazole sensitizes cancer cells to ionizing radiation. Radiat Oncol 2011;6:160. [ DOI:10.1186/1748-717X-6-160] 17. Michaelis M, Agha B, Rothweiler F, Loschmann N, Voges Y, Mittelbronn M, et al. Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen. Sci Rep 2015;5:8202. [ DOI:10.1038/srep08202]
|